With distribution partnerships and deployment agreements beginning to translate into measurable commercial traction, Nano-X ...

Nano-X just won FDA approval to generate 3D X-ray images with its Nanox.ARC X machines. Nano-X is not yet profitable and continues to burn cash. At current burn rates, the company could be out of ...

The average one-year price target for Nano-X Imaging (NasdaqGM:NNOX) has been revised to $6.78 / share. This is a decrease of 10.14% from the prior estimate of $7.55 dated April 12, 2026. The price ...

Good day, and thank you for standing by. Welcome to the Nano-X Q1 2025 Earning Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation there will be ...

Nano-X Imaging (NASDAQ: NNOX), the Israeli X-ray imaging company that hopes to disrupt the medical devices market with a business model charging per X-ray delivered rather than simply selling X-ray ...